Order

About Osgood-Schlatter Disease

Osgood-Schlatter Disease

Osgood-Schlatter Disease is defined by a characteristic soreness and swelling at the tibial tuberosity. It usually originates in those between the ages of 9 and 16 who are both physically active and in a “growth spurt”. AKA “growing pains” (http://orthopedics.about.com/cs/pediatricsurgery/g/growingpains.htm) if unresolved it can be painful, of long duration, and have permanent detrimental effects both on the bone, as well as on a young athlete’s potential for both immediate performance and future college scholarships.

A recent Finnish study found that 13% of the teenagers of that country had symptoms of
Osgood-Schlatter Disease. The disease was named after two physicians who defined it in 1903, Dr. Robert Osgood and Dr. Carl Schlatter. Currently there are over 25 million children in the United States of America who are in the susceptible age group. With over half of them engaging in some athletic activity, it is possible that 2
million American boys and girls may contract OS yearly. The initial injury is probably caused by the powerful quadriceps muscle pulling on the
attachment point of the patellar tendon during activities such as soccer, basketball, track and other sports. The subsequent inflammation makes it stubbornly persistent. Once found mainly in boys, it now happens almost as
frequently in girls.

Order now

Treatment

Until now the only widely used treatment for Osgood-Schlatter Disease was abbreviated as “RICE”. This stands for Rest, Ice, Compression and Elevation. Often non-steroidal anti-inflammatory drugs (NSAIDS) and/or physical therapy are also recommended. Unfortunately, most of the time these methods prove to be inadequate. Physical therapy will not address the main problem with OSD, which is the inflammation that prevents rapid healing. The condition, osteochondrosis at the tendon’s attachment point on the tibial tubercle, may also include microscopic bone chipping and tears. Only in the most extreme cases will there be separation of both cartilage and bone from the tibia.

However, based upon years of experience with OSD in young athletes in various sports and pursuits, there is a novel new product called Oscon. It appears to work on a variety of levels to help treat the painful condition. The method of action appears to be in at least three areas. First is the proven biological effect of certain vitamin E isomers on inflammatory free radicals. The most biologically active of these is RRR-a-tocopherol. Antioxidants such as vitamin E act to protect cells against the effects of free radicals, which are potentially damaging by-products of the body’s metabolism. Second is an increase in glutathione peroxidase due to the increased presence of selenium. This enzyme is the general name of an enzyme family with peroxidase activity whose main biological role is to protect the organism from oxidative damage. The biochemical function of glutathione peroxidase is to reduce lipid hydroperoxides to their corresponding alcohols and to reduce free hydrogen peroxide to water. Thirdly, these two micronutrients seem act synergistically to reduce inflammation and pain due to free-radical activity at an injury site. Vitamin E has long been recommended as a topical wound healer, and it appears that certain forms have that effect when taken internally. More research is continuing on just why this combination is so remarkably effective in cases of Osgood-Schlatter. Improvement is almost always seen in less than a week! Please contact us about your own experiences with Oscon. We are confident that you will be as pleased as we were when we first employed this formula.